The MOU aims to foster collaboration in utilizing nuclear medicine technologies to enhance patient care and medical capabilities at Ayady 4040 Hospital.


Alexandria, Egypt – Medscan Group, Rosatom’s subsidiary group of companies and one of the leaders in the non-state healthcare sector in Russia, signed a Memorandum of Understanding with Ayady 4040 Foundation/Association, a non-governmental organization providing free medical services for cancer treatment in Alexandria.


The memorandum was signed in light of Rosatom’s participation in the Africa Health Excon Exhibition, the biggest healthcare exhibition taking place in Cairo, Egypt. The memorandum confirms the parties' intentions to further implement joint projects aimed at utilizing non-energy nuclear technologies and developing nuclear medicine in Egypt. The collaboration will contribute to the development of infrastructure and the advancement of medical services in the country.


Antonina Filippovskaya, International Projects Director, Medscan Group:

“The signing of the MoU with Ayady 4040 Foundation/Association is an important result of our efforts to introduce advanced nuclear technologies in various areas of healthcare, including cancer treatment. Future cooperation will improve the expertise of Ayady Hospital and contribute to the development of nuclear medicine in the Arab Republic of Egypt. By introducing advanced technologies and raising the standards of treatment for cancer patients at Ayady Hospital, we will make a concrete and tangible contribution to improving the quality of life of those who need help."


“We are committed to providing innovative solutions that empower individuals to take control of their health and well-being through affordable, accessible, and effective healthcare technologies and services. The partnership with Medscan marks a significant step towards this goal particularly in the field of advanced cancer treatment. This collaboration will enable us to leverage cutting-edge radiation technologies and medical expertise, ultimately improving access to life-saving treatments for our patients and ensuring that individuals in need receive the best possible care and support on their journey to recovery", said Eng. Amr Aboul Seoud, Vice Chairman of Ayady 4040 Foundation / Association.


For reference:


Medscan, one of the leaders of the non-governmental healthcare sector in Russia, offering an ecosystem for daily health care based on deep expertise and developed infrastructure. The holding's medical institutions provide a full range of high-tech medical care according to the world's leading protocols. In 30 regions and 102 cities of Russia, there are 58 medical centers, 15 laboratories and 442 laboratory medical offices of the Medscan Group, including diagnostic centers, laboratories, hospitals with a surgical inpatient department, multidisciplinary and specialized clinics (including oncology), and research and development centers. The shareholders of the Medscan Group are Evgeny Tugolukov (50%) and Rosatom Health Technologies, a division accumulating the expertise of the Rosatom State Corporation in the field of healthcare (50%).


Ayady 4040 Foundation/Association, founded in 2001 by a group of philanthropists in Alexandria, has been providing various activities for those in need, including free treatment in private hospitals. In 2004, the foundation/association began the establishment of a free cancer treatment hospital, which started operating in January 2005 after installing the first linear accelerator for radiation therapy.